Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea

Microbial Drug Resistance

Volumn 17, Issue 2, 2011, Pages 299-304

  Lee, Ji Young ^a   Song, Jae Hoon ^a,b   Ko, Kwan Soo ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; RIFAMPICIN; SULPERAZON; SULTAMICILLIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; GENOTYPE; IN VITRO STUDY; KOREA; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, URBAN; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPUBLIC OF KOREA;

PSEUDOMONAS AERUGINOSA;

EID: 79957661264     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2010.0145     Document Type: Article

References (24)

1. Abraham, N. and D.H. Kwon. 2009. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 298:249-254.
2. Alina, P., N. Yeshayahu, and L. Tsilia. 2009. Identification of pathogenic bacteria in blood culture; Comparison between conventional and PCR methods. J. Microbiol. Methods 78:325-330.
3. Barrow, K., and D.H. Kwon. 2009. Alterations in twocomponent regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:5150-5154.
4. Clinical and Laboratory Standards Institute (CLSI). 2009. Performance Standards for Antimicrobial Susceptibility Testing, 19th Informational Supplement, M100-S19. CLSI, Wayne, PA.
5. Curran, B, D. Jonas, et al. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649. (Pubitemid 39664348)
6. Falagas, M.E., P.I. Rafailidis, D.K. Matthaiou, S. Virtzili, D. Nikita, and A. Michalopoulos. 2008. Pandrug-resistant Klebsiella pneumonia, Pseudomonas aeruginosa, and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int. J. Antimicrob. Agents 32:450-454.
7. Fernández, L., W.J. Gooderham, M. Bains, J.B. McPhee, I. Wiegand, and R.E.W. Hancock. 2010. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel twocomponent regulatory system ParR-ParS. Antimicrob. Agents Chemother. 54:3372-3382.
8. Hawley, J.S., C.K. Murray, and J.H. Jorgensen. 2008. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob. Agents Chemother. 52:351-352.
9. Ko, K.S., J.-Y. Suh, K.T. Kwon, S.I. Jung, K.H. Park, C.I. Kang, D.R. Chung, K.R. Peck, and J.-H. Song. 2007. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 60:1163-1167. (Pubitemid 47617772)
10. Landman, D., S. Bratu, M. Alam, and J. Quale. 2005. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B. J. Antimicrob. Chemother. 55:954-957. (Pubitemid 40883181)
11. Landman, D., C. Georgescu, D.A. Margin, and J. Quale. Polymyxins revisited. Clin. Microbiol. Rev. 21:449-465.
12. Lee J, G. Patel, S. Huprikar, D.P. Calfee, and S.G. Jenkins. Decreased susceptibility to polymyxin B during treatment of carbapenem-resistant Klebsiella pneumoniae infection. J. Clin. Microbiol. 47:1611-1612.
13. Li, J., C.R. Rayner, R.L. Nation, et al. 2006. Hetero-resistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:2946-2950. (Pubitemid 44396396)
14. Li, J., R.L. Nation, R.J. Owen, S. Wong, D. Spelman, and C. Franklin. 2007. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Clin. Infect. Dis. 45:594-598. (Pubitemid 47328640)
15. Lister, P.D., D.J. Wolter, and N.D. Hanson. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610.
16. McPhee, J.B., S. Lewenza, and R.E.W. Hancock. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217. (Pubitemid 37222798)
17. Mendes, R.E., T.R. Fritsche, H.S. Sader, and R.N. Jones. Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates. Clin. Infect. Dis. 46:1324-1326.
18. Mitrophanov, A.Y., M.W. Jewett, T.J. Hadley, and E.A. Groisman. 2008. Evolution and dynamics of regulatory architectures controlling polymyxin B resistance in enteric bacteria. PLoS Genet. 4:e1000233.
19. Moffatt, J.H., M. Harper, P. Harrison, J.D. Hale, E. Vinogradov, T. Seemann, R. Henry, B. Crane, F. St. Michael, A.D. Cox, B. Adler, R.L. Nation, J. Li, and J.D. Boyce. 2010. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54:4971-4977.
20. Moskowitz, S.M., R.K. Ernst, and S.I. Miller. 2004. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186:575-579. (Pubitemid 38076447)
21. Park, Y.K., S.I. Jung, K.H. Park, H.S. Cheong, K.R. Peck, J.H. Song, and K.S. Ko. 2009. Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn. Microbiol. Infect. Dis. 64:51-59.
22. Suh, J.-Y., J.S. Son, D.R. Chung, K.R. Peck, K.S. Ko, and J.-H. Song. 2010. Nonclonal emergence of colistin-resistant Klebsiella pneumonia isolates from blood samples in South Korea. Antimicrob. Agents Chemother. 54:560-562.
23. Tan, T.Y., and S.Y. Ng. 2006. The in-vitro activity of colistin in gram-negative bacteria. Singapore Med. J. 47:621-624. (Pubitemid 44048976)
24. Wang, C.Y., J.S. Jerng, K.Y. Chen, L.N. Lee, C.J. Yu, P.R. Hsueh, and P.C. Yang. 2006. Pandrug-resistant Pseudomonas aeruginosa among hospitalized patients: clinical features, riskfactors and outcomes. Clin. Microbiol. Infect. 12:63-68. (Pubitemid 43372241)